Skip to content
Use caution Medical device recall · FDA · Published September 20, 2022

Medtronic MiniMed 600 Series Insulin Pumps Recall: Cybersecurity Vulnerability Risk

Medtronic recalls MiniMed 620G and 640G insulin pumps due to a cybersecurity vulnerability that could allow unauthorized insulin delivery, risking hypoglycemia or hyperglycemia. Learn what to do.

🇺🇸 FDA recall #Z-0194-2023Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic MiniMed18000 Devonshire St · Northridge, CA 91325-1219
✎ GovInfoNow plain-language explainer

Medtronic is recalling several models of insulin pumps (MiniMed 620G and 640G) because of a cybersecurity flaw that could let hackers control insulin delivery, potentially causing dangerous blood sugar levels. This affects people who use insulin pumps for diabetes management. Read more at govinfonow.com/recall/60038-medtronic-minimed-600-series-insulin-pumps-recall-cybersecurity-vulnerability-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/60038-medtronic-minimed-600-series-insulin-pumps-recall-cybersecurity-vulnerability-risk · Updated August 10, 2026 · FDA enforcement record: FDA #Z-0194-2023

Cite this page

“Medtronic MiniMed 600 Series Insulin Pumps Recall: Cybersecurity Vulnerability Risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/60038-medtronic-minimed-600-series-insulin-pumps-recall-cybersecurity-vulnerability-risk. Based on FDA recall #Z-0194-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0194-2023%22&limit=1).

The FDA announced on Sept. 20, 2022, that Medtronic MiniMed is recalling MiniMed 620G and 640G insulin pumps due to a cybersecurity vulnerability allowing unauthorized access. Owners should turn off the Remote Bolus feature to prevent this risk.

How to tell if you have it

  • MiniMed 620G (MMT-1750)
  • MiniMed 640G (MMT-1711, MMT-1712, MMT-1751, MMT-1752)

The hazard

The FDA said the vulnerability in the communication protocol could allow unauthorized access to deliver unintended insulin boluses or stop delivery, leading to hypoglycemia or hyperglycemia. The agency noted that the Remote Bolus feature should be turned off to prevent unauthorized access.

Context

GovInfoNow's records show Medtronic MiniMed has issued five other recalls since June 27, 2019. Recent similar product recalls include the Medtronic Guardian App recall on Nov. 21, 2022, and insulin pump recalls on May 23, 2022, and Jan. 27, 2022. Other recent recalls of similar products include the Medtronic MiniMed 780G Insulin Pump Recall (July 13, 2026), the Medtronic MiniMed 640G Insulin Pump Recall (July 13, 2026), and the Medtronic MiniMed 670G Insulin Pump Recall (July 13, 2026).

How to tell if you have this one

Check if your pump has a model number starting with MMT-1750, MMT-1711, MMT-1712, MMT-1751, or MMT-1752. The specific serial numbers are listed in the recall notice for each model.

  • Brand
    Medtronic
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY. OUS: Andorra, Australia, Austria, Barbados, Belgium, Bermuda, Bolivia, Botswana, Canada, Canary Islands, Cayman Islands, Chile, Czech Republic, Denmark, Dominican Rep., El Salvador, Faroe Islands, Finland, France, Germany, Gibraltar, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Kenya, Liechtenstein, Luxembourg, Mauritius, Mexico, Namibia, Netherlands, New Zealand, Norway, Paraguay, Peru, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Trinidad and Tobago, Turkey, Uganda, United Kingdom, Venezuela
Recall numberProduct, codes & lotsQuantity
Z-0193-2023Insulin Pump/Model: MiniMed 630G/ MMT-1715, MMT-1755, MMT-1754; MiniMed 670G/ MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742; Model/UDI-GTIN(All Serial Numbers): MMT-1715/643000000000, 763000072520, 643169873834, 00643169656840; MMT-1755/643169752726, 643169873841, 643169878648, 763000179632, 00643169752726; MMT-1754/643169976344; MMT-1780/643169949706, 643169939202, 763000072537, 643000000000, 00643169939219; MMT-1781/763000187415, 763000283568, 00763000140601, 00763000225575, 00763000235765, 00763000187415, 00763000283551, 00763000240707; MMT-1782/763000187422, 763000283599, 00763000140618, 00763000225612, 00763000235772, 00763000187422, 00643169957640, 00763000283582; MMT-1760/643169946040, 763000278427, 763000179649, 643169946057, 763000367084, 00643169946057; MMT-1761/00763000367657, 00763000165413; MMT-1762/00763000239404, 00763000203313, 00763000216481, 00763000187408, 00763000165475; MMT-1740/Investigational; MMT-1741/00763000303556, 00763000408916; MMT-1742/00763000250232399651
Z-0194-2023Insulin Pump/Model: MiniMed 620G/ MMT-1750 MiniMed 640G/ MMT-1711, MMT-1712, MMT-1751, MMT-1752; Model/UDI-GTIN (All Serial Numbers): MMT-1750/00763000375461, 00643169559745; MMT-1711/643169554931, 763000367039, 00643169890039, 00643169554917, 00643169629813, 00643169554924, 00643169554931, 00643169742062, 00763000013066, 00643169554948, 00643169554955, 00643169621954; MMT-1712/643169662612, 643169577701, 00763000205409, 00643169890046, 00643169577664, 00643169629820, 00643169577671, 00643169577688, 00763000155346, 00643169577695, 00643169577701, 00643169621961; MMT-1751/643169672239, 00643169574410, 00643169574427, 00643169574434, 00763000253288, 00643169574441, 00643169574458, 00643169643512, 00643169521155, 00643169521704, 00763000015596, 00643169520882, 00643169521421, 00643169521971; MMT-1752/763000192181, 00643169596368, 00643169596382, 00643169596405, 00763000318291, 00763000318307, 00643169596443, 00643169522305, 00643169521292, 00643169522381, 00643169521841, 00643169522268, 00643169521025, 00643169522343, 00643169521575, 00643169522114316326
Based on the official FDA remedy

What to do — step by step

  1. Turn Off Remote Bolus Feature

    Disable the Remote Bolus feature in your pump settings to prevent unauthorized insulin delivery.

Where it went and when

Where it was distributed

Distributed in 50 states and D.C. and Puerto Rico, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY. OUS: Andorra,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 57 days after the firm started it.

1. Firm started the recall: Sep 20, 202212. FDA classified it Class II: Nov 7, 202223. Published in FDA’s Enforcement Report: Nov 16, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0194-2023 (September 20, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0194-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA